This Weekly’s Hot Topics
- Trump administration to require drug companies to include price of drug in television advertisements. National News
- Tomorrow is last day to review and dispute Open Payments. CMS News
- ASCO invites your review of clinical guidelines, by May 16. Affiliate Association News
Gov. Gavin Newsom’s administration reversed course on his plan to divert public health dollars from several counties to help provide health coverage to young adults who are in the country illegally. The administration considered the concerns of Sacramento, Placer, Santa Barbara and Stanislaus counties, which had warned that the governor’s plan would compromise their ability to cope with surging rates of sexually transmitted diseases and, in some cases, measles outbreaks. To read more click here and go to California News.
The drugs included everything from tablets and capsules to creams and ointments to treat conditions including cancer and more. U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with other drug companies to inflate drug prices – sometimes by more than 1,000%, and stifle competition for generic drugs, state prosecutors said on Saturday. To read more click here and go to National News.
Tomorrow, May 15, is last day for U.S. physicians to review and dispute Open Payments data before it is made public on June 30. Review of the data is voluntary, but strongly encouraged to help improve the accuracy of the reported data. To read more click here and go to CMS News.
Through May 16, ASCO invites key stakeholders to critically review and identify any errors in draft clinical practice guidelines prior to their finalization and publication. One draft clinical practice guideline or update is now open for comment–germline and somatic tumor testing in epithelial ovarian cancer. To read more click here and go to Afilliate Association News.
To read the complete California Oncology Weekly Newsletter, click on the date below.